Skip to main content
Premium Trial:

Request an Annual Quote

Sophia Genetics Gains CE-IVD Mark for Leukemia Assay

CHICAGO (GenomeWeb) – Sophia Genetics said that it has received a CE-IVD mark for a molecular diagnostics test designed to improve detection of leukemia and other hematological diseases. The Swiss company called this the "world’s first capture-based myeloid clinical solution" to receive this designation from European regulators.

The test is a sequencing-based assay combined with data analytics to detect mutations that cause myeloid and lymphoid leukemia.

According to Lausanne, Switzerland-based Sophia, its technology helps improve genome reads and coverage uniformity, even in areas heavy in Gs and Cs. This, Sophia said, overcomes analytics limitations associated with biomarkers such as CEBPA, FLT3, and CALR.

Sophia Genetics said that its new myeloid test will support both biomarker-driven drug discovery and the personalization of cancer care.

Last week, the company announced that its Sophia AI machine learning platform now supports radiomics analysis. Sophia raised $30 million in a Series D round of venture capital last September.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.